Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 15532979)

1.

Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin.

Fan E, O'Neal CJ, Mitchell DD, Robien MA, Zhang Z, Pickens JC, Tan XJ, Korotkov K, Roach C, Krumm B, Verlinde CL, Merritt EA, Hol WG.

Int J Med Microbiol. 2004 Oct;294(4):217-23. Review.

PMID:
15532979
2.
4.

Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review).

De Haan L, Hirst TR.

Mol Membr Biol. 2004 Mar-Apr;21(2):77-92. Review.

PMID:
15204437
5.

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.

Rappuoli R, Pizza M, Douce G, Dougan G.

Immunol Today. 1999 Nov;20(11):493-500. Review. No abstract available.

PMID:
10529776
6.

Membrane traffic and the cellular uptake of cholera toxin.

Lencer WI, Hirst TR, Holmes RK.

Biochim Biophys Acta. 1999 Jul 8;1450(3):177-90. Review.

7.

AB5 ADP-ribosylating toxins: comparative anatomy and physiology.

Burnette WN.

Structure. 1994 Mar 15;2(3):151-8. Review.

PMID:
8069630
8.

Protein crystallography and infectious diseases.

Verlinde CL, Merritt EA, Van den Akker F, Kim H, Feil I, Delboni LF, Mande SC, Sarfaty S, Petra PH, Hol WG.

Protein Sci. 1994 Oct;3(10):1670-86. Review.

9.

Escherichia coli cytotoxins and enterotoxins.

Gyles CL.

Can J Microbiol. 1992 Jul;38(7):734-46. Review.

PMID:
1393838
10.

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.

Williams NA, Hirst TR, Nashar TO.

Immunol Today. 1999 Feb;20(2):95-101. Review.

PMID:
10098329
11.
12.

Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development.

Burnette WN, Cieplak W Jr, Kaslow HR, Rappuoli R, Tuomanen EI.

Bioprocess Technol. 1994;19:185-203. Review. No abstract available.

PMID:
7764758
14.

Gangliosides as receptors for bacterial enterotoxins.

Fishman PH, Pacuszka T, Orlandi PA.

Adv Lipid Res. 1993;25:165-87. Review. No abstract available.

PMID:
8396312
15.

Intracellular transport and processing of protein toxins produced by enteric bacteria.

Sandvig K, Garred O, van Deurs B.

Adv Exp Med Biol. 1997;412:225-32. Review.

PMID:
9192018
16.

[Studies on the mode of action of bacterial AB5 toxins].

Noda M.

Nihon Saikingaku Zasshi. 2013;68(3):299-311. Review. Japanese.

17.
18.

Mechanism of action of cholera toxin & other toxins.

Ganguly NK, Kaur T.

Indian J Med Res. 1996 Jul;104:28-37. Review.

PMID:
8783505
19.

LTK63 and LTR72, two mucosal adjuvants ready for clinical trials.

Pizza M, Giuliani MM, Fontana MR, Douce G, Dougan G, Rappuoli R.

Int J Med Microbiol. 2000 Oct;290(4-5):455-61. Review. No abstract available.

PMID:
11111926
20.

Bacterial toxin inhibitors based on multivalent scaffolds.

Branson TR, Turnbull WB.

Chem Soc Rev. 2013 Jun 7;42(11):4613-22. doi: 10.1039/c2cs35430f. Epub 2012 Dec 21. Review.

PMID:
23263178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk